Presentation

My Research

Lipoproteins are nanosized particles in the blood that transport fats and cholesterol between the body's tissues. When these particles undergo structural changes, they can contribute to serious diseases, from atherosclerosis to systemic amyloidosis, a condition in which proteins misfold and accumulate in organs with potentially life-threatening consequences.

The overarching goal of my research is to understand the relationship between lipoprotein structure and biological function, with a particular focus on high-density lipoproteins (HDL) and apolipoprotein A-I. By mapping how structural alterations affect lipid transport, cholesterol efflux, and interactions with biological membranes, we can identify mechanisms underlying disease development. Building on this knowledge, we develop reconstituted HDL nanoparticles as therapeutics, with applications in cancer and cardiovascular disease.

Alongside this work, I pursue research in sustainable biotechnology, exploring novel strategies for protein production and nutrient encapsulation with applications in food technology. While distinct from my lipoprotein research, both lines of inquiry share a common foundation in understanding how molecular interactions can be harnessed to address challenges in human health.

Publications

Achievements